PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24637190-13	2014	Compared to CCl4 model group, Sorafenib and XFZY decreased alpha-SMA, collagen I, CD31, VEGF, VEGFR-2, HIF-1alpha and ADMA, and increased the expression of DDAH1.	Sorafenib	30-39	actin alpha 2, smooth muscle, aorta	Mus musculus	59-68